|
Morgan “Caitlin” McKenna
Director, Office of Grant Support (OGS)
Phone: 718-430-3642
Email: morgan.mckenna@einsteinmed.edu
| |
Message from the Director
Hello,
In this February edition of the newsletter, I will provide details on our institutional submissions, office updates, sponsor updates, internal forms changes, system updates and proposal reminders.
Application Breakdown
Applications numbers have been analyzed for January 1 – February 28, 2025. OGS has already reviewed 235 applications (196 New, 10 Renewal, 23 Resubmission, 6 Supplement). The total cost request is $284,614,036. These applications were submitted by 46 Departments/Divisions across the institution. The funding breakdown: 44% Federal prime, 30% Federal and Non-Federal subcontracts, 20% Non-Federal prime, 4% Industry, and >1% New York State and >1% International. We are currently reviewing 11 applications for the remainder of February deadlines. We have 28 applications under review for March 5th NIH deadline.
| | |
|
We are reviewing the impact of executive orders on our NIH grant awards. If you receive notice that your grant will be impacted by the executive orders please contact OGS.
OGS Office Updates and Reminders
We are recruiting for a Senior Grant Specialist and a Grant Specialist. Come join our team!
Resource - Funding: OGS maintains an active license with SPINPlus portal. This portal has over 40,000 funding opportunities and allows investigators to set filters and receive notifications from the system of new field specific opportunities as they become available. Registration for March 12th at this link.
Reminder - Communication: Please ensure that communication and sponsor required clarifications route through OGS. As the Authorized Organization Representatives (AOR), we will review, provide feedback, and offer our concurrence for all direct sponsor communications.
Reminder – ProposalCentral: If you are submitting to a non-federal sponsor using ProposalCentral and you require institutional signature, you need to list the appropriate central office staff and provide edit access for the collection of signatures. All ProposalCentral full applications require an approved Cayuse record.
Reminder – Federal Applications: SF424 R&R page 1 “Person to be contacted on matters involving this application” list administrator information or Indranil Basu or Morgan McKenna. If you are submitting a DoD application list only OGS contact. SF424 R&R page 2 section for Authorized Representative please list Indranil Basu or Morgan McKenna. Applicant information should include Division as “Albert Einstein College of Medicine.”
Submission Policy Clarification (Enforcement 3/5 Deadline): OGS requires the routing of proposals 8 business days prior to deadline for administrative documents. This includes the final budget, justification(s), Data Management and Sharing Plan (if applicable), biosketch of all key personnel, subcontract documents (signed SOI, performance site, biosketch of key persons, budget, and justification). If complete, you can also upload the Facilities and Other Resources, Equipment, Key Authentication, Vertebrate animal document and the Protection of Human Subjects and study record documents.
If you are collaborating with a foreign site(s), you are required to provide a signed letter of support for each site with the language listed on the supplemental form for OGS review.
We request the upload of final science 2 days prior to deadline (NIH recommendation).
Reminder - Routing: All Cayuse applications require full routing and budget approval prior to submission to sponsors.
Reminder – New Sponsors: If you plan to work with a new sponsor, it is important that OGS review contract and/or award terms. Please route language to OGS prior to submission.
Reminder (Holiday or Office Closure): OGS will have coverage for urgent signatures and application deadline support. Please be proactive and route applications and signature requests to OGS in advance.
Federal Sponsor Updates and Resources
NIH Updates:
NIH has implemented Forms I for all applications with deadlines on or after January 25th, 2025.
Common Forms- Adoption for Biographical Sketch and Current and Pending (Other Support) for all submissions on or after May 25th, 2025 (NOT-OD-24-163).
Peer Review – Simplified Review Framework for NIH Research Project Grant Applications (NOT-OD-24-010). This new framework and structure will begin with submission for due dates on or after January 25th, 2025. Information concerning the framework is included in updated FONs. Resources for Simplified Review Framework webinar and overview of changes are available here.
Data Management and Sharing Plan (DMSP): OGS is not involved in the implementation of the DMSP. Please do not list OGS, RF, or any other central office on Element 6 of the plan, as this should be project personnel. OGS and Einstein IT are working on template language to share concerning institutional resources.
NIH Data Access and Security: Effective January 25, 2025, new and renewal users will be expected to secure data according to updated NIH Security Best Practices. Updated requirement for security of controlled-access data NOT-OD-24-157. 20 NIH Controlled access repositories (dbGAP, NDA, NIAGADS, etc.). Einstein IT will prepare plan to comply with regulation. Webinar: Community-Days-Securing-NIH-Controlled-Access-Genomic-Data.pptx
NIH – Clarification: NIH does not allow for overlapping or duplicative funding. Please read the extramural article on research integrity. Link: https://nexus.od.nih.gov/all/2024/10/04/the-how-and-why-of-recovery-of-grant-funds/
Upcoming Form and System updates: The required Cayuse Supplemental form is under review. Several units and administrators have contributed suggestions, which will be incorporated. This new form 5.1 will be circulated for use when the review is complete.
Reminder – Early Approval: Cayuse has added a required field to the proposal in SP (Early Approval /Submission Request). If you require an early review, select Yes, and enter the date in the text box. If you do not require an early review, select No. Please ensure your review request is consistent with the submission policy and provides reasonable turnaround time for OGS review. All documents should be complete and correct to ensure an early review can be completed on the requested date.
Training: Cayuse training will continue to be available monthly. Please contact OGS to request inclusion (OGS@einsteinmed.edu). OGS is creating training in specific areas including Other Support, Common Forms, and Budget Development.
Other support training was provided on February 11th. The recording can be shared.
Additional training will be available in the first quarter of 2025. More information to come.
Please continue to reach out to OGS for all your research administrative related inquiries. We look forward to continuing to provide a high level of support for your applications as well as clear updates on sponsor’s requirements and guidance to maximize funding success!
Sincerely,
M. Caitlin McKenna
| | |
|
How to find the grant opportunity via SPIN Plus Portal?
Wednesday, March 12th from 11 am – 12 pm
Mr. Bill DeCocco, Account Manager for InfoED Global, will be demonstrating live via Zoom how to use SPIN Plus Portal – one of the world’s largest databases of sponsored funding opportunities. Bill will cover all main aspects of SPIN Plus during the presentation and address any questions that may arise. Click here to register.
| |
Important links and documents | |
|
I) Einstein's institutional information, including UEI#, EIN#, New IPF#, Congressional District, and more, can be accessed by clicking here.
II) The Einstein Pre-Award Forms (which include Cayuse Supplemental 5.0, eRA Commons account request, Cayuse user request, New Sponsor, PI certification, SOI lead and non-lead, and more) are available for download from this page.
III) Types of Letters for Grant Applications: Learn when and how to submit a reference letter, cover letter, letter of intent, letter of support and other documents. Each key letter has a distinct purpose in informing peer reviewers, NIH staff, or both. Certain letters may be necessary while others are optional or should be left out, depending on your research plans and the type of your application. The subpages contain instructions on how to use each type of letter and what is required.
| | |
|
Timeline for Assignment, Review, and Council
Your application is evaluated by NIH and assigned to an institute. The peer review process occurs four or five months after the NIH deadline. The majority of applications are submitted to the full Council meeting about seven months after the due date.
Click here to view the graphic that marks this phase of the process.
| | |
NOT-OD-25-026: Reminder: FORMS-I Grant Application Forms and Instructions Must be Used for Due Dates On or After January 25, 2025 | Reminder: The FORMS-I Grant application forms and instructions must be used for due dates on or after January 25, 2025. Early submission is encouraged for applicants to have time to work through any unforeseen issues. | | | |
NOT-HS-25-015: Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2025 | This Notice provides information regarding the salary limitations for AHRQ grant and cooperative agreement awards, as well as extramural research and development contract awards. AHRQ competing grants and cooperative agreements and contracts, grant applications, and contract proposals that request direct salaries for individuals in excess of the applicable rate of $225,700 per year (or $108.51 per hour for a full-time appointment of 2080 hours per year) will be adjusted in accordance with the Executive Level II salary limitation and will include notification of this adjustment. Adjustments will be made in the current and all future years; no funds will be awarded, committed, or disbursed in excess of the salary cap limitation. | | | |
Non-Federal Funding Opportunities | |
CFF Physician Training & Career Development Programs RFAs | |
Clinical Fellowships, LeRoy Matthews Award, and the Harry Shwachman Award:
These programs aim to attract, develop, and retain exceptional clinicians and investigators into cystic fibrosis care and research to address the evolving needs of the CF community.
Applications to all Physician Training and Career Development Programs must be submitted online at awards.cff.org by February 26, 2025.
For questions, please contact Elizabeth Yu (eyu@cff.org).
| | | |
Novel Artificial Intelligence Approaches to Advance Cardiovascular and Cerebrovascular/Brain Health | |
The American Heart Association announces this funding opportunity to advance the use of Artificial Intelligence in health and health care delivery.
A total of $12 million is available to fund three investigators / investigative teams proposing novel uses of Artificial Intelligence to revolutionize cardiovascular and cerebrovascular / brain health and health care delivery.
Pre-proposal deadline is Thursday, February 27, 2025
| | | |
Lupus Foundation of America's 2025 Grant Opportunities | |
Grant Funding Opportunities are available for:
Medical and Graduate Students
Clinical and Postdoctoral Fellows
Established investigators conducting pediatric lupus research
Investigators based in Canada
Application Deadline: February 27, 2025
Grant Amounts: $4,000-$140,000
To learn more about the application process, eligibility criteria, and specific focus areas, please visit the Lupus Foundation of America's website. You will find comprehensive guidelines and details on how to submit your proposal successfully. Please email crump@lupus.org with any questions.
| | | |
Craig H. Neilsen Foundation (Spinal Cord Injury): Psychosocial Research | |
• Due: March 06, 2025 (LOI)
• Amount: $200,000-$550,000 depending on award type
• To support research that prioritizes the interrelation of behavioral, social, psychological, and other factors that will increase the quality of life factors for individuals living with spinal cord injury. Priority areas include aging, caregiving, employment, health and fitness, independent living, self-management, and technology access. Awards are available for Postdoctoral Fellows ($200,000 over 2 years), Pilot grants ($300,000 over 2 years), or Studies and Demonstrations ($550,000 over 3 years) which “encourage substantive research that fill important gaps in the spinal cord injury field, that open new areas of psychosocial research, and/or that develop and evaluate interventions to address psychosocial issues after spinal cord injury.”
• Click here for further details.
| | | |
Early Detection Award | The Mark Foundation for Cancer Research | |
· Due: March 10, 2025 (LOI)
· Amount: $2,000,000/2 years
The foundation will fund projects focused on accelerating the development of effective new approaches to the early detection of cancer. The projects will advance our understanding of the origins and risk stratification of recalcitrant cancers and accelerate the development of technological and methodological innovation in early cancer detection and interception. Ideas that are broadly applicable to early detection across multiple cancer types are encouraged, including the development of novel clinical trial statistical methodologies that aim to assess the validity of early detection biomarkers. Applicants should propose an innovative idea that extends beyond incremental improvements to existing technologies. Proposals involving animal modeling should incorporate plans for additional validation in patients. Similarly, proposals that rely heavily on cell lines and/or organoids should consider validation in more complex models. Projects focused on cancer prevention rather than early cancer detection and diagnosis are not in the scope of this RFP. Eligible Cancer Types: Pancreatic cancer, Hepatobiliary cancers (hepatocellular carcinoma, gallbladder and bile duct cancers, cholangiocarcinoma), Ovarian cancer, Glioblastoma, Upper GI cancers (esophageal, gastric cancer), and Cancers resulting from hereditary cancer predisposition syndromes. PI Eligibility: Applicants must have an independent faculty research appointment; no restrictions on citizenship or geography; investigators may apply as a team of two to four investigators (one PI and up to three co-investigators); teams may comprise investigators from a single or multiple institutions.
· Link: Mark Early Detection Award
For any inquiries related to Mark Foundation Award, please reach out to Audrey McInerney (amcinerney@montefiore.org).
| | | |
|
· Due: March 10, 2025 @ 3pm ET
· Amount: $225,000 over 3 years
The foundation seeks applications from early-career basic scientists, medical oncologists, pathologists, urologists, radiologists, radiation oncologists, public health experts, bioinformaticians, bioengineers, or professionals from any other field that could contribute to the end of potentially lethal prostate cancer. Applicants may be working in basic, translational, computational, or clinical research and need not be trained specifically in prostate cancer research to be highly competitive. Access to and real-time interaction with a clinical environment and translational prostate cancer physician-scientists is highly desired. “Small step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients. Young investigators working on prostate cancer health disparities to apply are especially encouraged to apply. Applicants traditionally under-represented in science and medicine are highly encouraged. Research proposals addressing disparities in care experienced by patients with prostate cancer may focus on implementation research in various populations (e.g., urban vs rural, racial, geographic, or financial) or in drivers of care and outcome disparities that could potentially be addressed through changes in policy, advocacy, or education. Eligibility: Must be within six years following completion of a professional degree or subsequent mentored academic or clinical training program. Must hold title of Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor or equivalent. Must be under the direct supervision of a mentor(s). At least one mentor at the applicant’s institution is required. The Applicant should not have been granted more than $1,000,000 in direct research funding from all sources including institutional funds(startup funds excluded) at the time of application. If so, please contact PCF to discuss your eligibility.
· Link: YIA RFP
For any inquiries related to Prostate Cancer Foundation Award, please reach out to Audrey McInerney (amcinerney@montefiore.org).
| | | |
Distinguished Scientist Award | The Sontag Foundation | |
The Sontag Foundation, Ponte Vedra Beach, Florida, is one of the largest private funders of brain cancer research in North America. The Foundation is soliciting applications for its Distinguished Scientist Award. $750,000 in funding over 5 years is open to early career investigators throughout the United States. The goal of this funding initiative is to change the paradigm of brain cancer research by building a community of outstanding scientists whose pioneering approaches have the potential to make significant advances in the field of brain cancer/brain tumors. The applications are due on March 12, 2025 at 11:59pm ET. Please click here to find the grant guidelines.
Eligibility - Applicants must hold a doctoral degree in a discipline with applicability to brain cancer research. Applicants must have received their first independent faculty appointment no earlier than March 1, 2020 and no later than January 1, 2025 at a tax-exempt academic, research, or medical institution within the United States or an equivalent institution in Canada. If the institution grants tenure, the qualifying appointment must be on tenure track. More than one individual from the same institution may apply for this award. This grant does not support clinical trials research. For further inquiries, please contact Shandra Koler, Senior Program Officer, phone: 904-273-8755 and Email: skoler@sontagfoundation.org.
| | | |
Damon Runyon Fellowship Award Overview |
- Due: March 17, 2025 @ 4pm
- Amount: $292,000
Damon Runyon views cancer research very broadly, including the full spectrum of basic questions important to normal human biology and carcinogenesis, as well as development of new platforms and technologies. The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies, and prevention. Must have a mentor. Criteria include quality of research proposal, qualifications, experience and productivity of both candidate and mentor, and quality of research training environment. Direct extensions of the candidate's graduate work (in approach, technique, or exact area of study) will not be funded. Physician-scientists must devote their principal time (at least 80 percent) to Damon Runyon-supported research activities. Activities constituting the remaining 20 percent of time should be clearly specified in the application and in the annual progress report. Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. Candidates who have already accepted a postdoctoral research fellowship award are not eligible.
· Link: Damon Runyon Fellowship Award Overview
For any inquiries related to Damon Runyon Fellowship Award, please reach out to Audrey McInerney (amcinerney@montefiore.org).
| | | |
Breast Cancer Alliance 2026 Exceptional Project Grants | |
• Due: March 31, 2025
• Amount: $100,000/1 year
• Limited submission 2 LOIs per institution. This award recognizes creative, unique, and innovative research. Proposal must focus on breast cancer. There is no limitation on the subject matter of the project if it is reasonably related to the treatment, prevention, or cure of breast cancer. However, the proposed project should be an exceptional project that can stand alone. The LOI must include hypothesis, outline of research aims and methods, and project’s potential impact.
Eligibility: Clinical doctors and research scientists at any stage of their career, including postdocs. You do not have to be a US citizen to apply.
• Please contact the Institutional Giving team at institutionalgiving@montefiore.org and click here for further details.
| | | |
Breast Cancer Alliance 2026 Young Investigator Grants | |
• Due: March 31, 2025
• Amount: $125,000 over two years
• Limited submission 2 LOIs per institution. Proposal must focus on breast cancer. This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support but who design and conduct their own independent research projects. The LOI must include hypothesis, outline of research aims and methods, and project’s potential impact.
Eligibility: Clinical doctors and research scientists who are in the early stages of their careers, including post docs. Applicants must (i) not have held a tenure track faculty or tenure track research position for more than four years following completion of their training, as of March 1, 2025; (ii) not have been or are not a principal investigator on an NIH R01 or equivalent national/international non-mentored award as of March 1, 2025; and (iii) dedicate at least 50% of their work effort to research. You do not have to be a US citizen to apply.
• Please contact the Institutional Giving team at institutionalgiving@montefiore.org and click here for further details.
| | | |
ASCO Career Development Award | The Career Development Award (CDA) provides research funding to clinical investigators who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. The research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. Applications in all areas of cancer research are accepted from U.S. and international applicants.The CDA is a three-year grant totaling $200,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants and Awards Ceremony at the ASCO Annual Meeting. The details of eligibility, application instructions and the due date (March 31, 2025) can be found here. | | | |
ASCO Young Investigator Award | The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. Applications in all areas of cancer research are accepted from U.S. and international applicants. The YIA is a one-year grant totaling $50,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants & Awards Ceremony at the ASCO Annual Meeting. Applicants who are selected to receive a YIA are allowed to receive other grants from other funding agencies. The details of eligibility, application instructions and the due date (March 31, 2025) can be found here. | | | |
|
Clinical Research Awards are given to aid investigator-initiated clinical research projects that have the potential to make a significant impact on the Cystic Fibrosis Foundation's mission. Research projects may address diagnosis, treatment, management of disease or symptoms, or the pathophysiology of cystic fibrosis using clinical (observational/ interventional), translational, or epidemiologic study approaches. Applicants must have access to a sufficient number of CF patients and appropriate controls. To learn more about the Multiple-PI option, prospective candidates should contact Dara Riva, the Program Officer, at driva@cff.org.
Up to $150,000 per year (plus 12% indirect costs) for a maximum of three years may be requested for single-center clinical research awards.
Multi-center clinical research may receive an award of up to $350,000 per year (plus 12% for indirect costs) for a maximum of three years.
Additional funding of up to $50,000 may be available for the entire project period through supplemental funding. To obtain complete submission information, please review the Spring 2025 Policies and Guidelines.
Deadlines:
The Fall 2025 cycle requires submission of letters of intent and full applications online at awards.cff.org by 5 p.m. ET.
Fall 2025
Letter of Intent: April 3, 2025
Full application: August 14, 2025
Those who are interested in any funding programs offered by the Foundation may receive further information or discuss the potential relevance of their studies or research by contacting Angela Minucci, the pre-award specialist for this program, at aminucci@cff.org.
| | | |
Clinical Pilot and Feasibility Award | |
Clinical Pilot and Feasibility Awards are offered to support projects involving human subjects (see 45 CFR 46.102(f)) that will develop and test new hypotheses and/or new methods being applied to the problems of cystic fibrosis for the first time and to assist promising new researchers in establishing themselves in research areas related to cystic fibrosis. The intent of these awards is to enable investigators to collect sufficient preliminary data to determine the best strategies and methods for approaching a major question that ultimately will require assessment through a larger-scale research and/or multi-center, collaborative trial.
Support may be requested for $80,000 per year (plus 12% for indirect costs) for single-center studies; and up to $150,000 per year (plus 12% indirect costs) for multi-center clinical studies for up to two years. An additional $100,000 can be obtained through supplemental funding for the entire project period.
To obtain complete submission information, please review the Spring 2025 Policies and Guidelines.
Deadlines:
The Fall 2025 cycle requires submission of letters of intent and full applications online at awards.cff.org by 5 p.m. ET.
Fall 2025
Letter of Intent: April 3, 2025
Full application: August 18, 2025
Those who are interested in any funding programs offered by the Foundation may receive further information or discuss the potential relevance of their studies or research by contacting Angela Minucci, the pre-award specialist for this program, at aminucci@cff.org.
| | | |
Emerging Leader Award | The Mark Foundation for Cancer Research | |
Due: May 5, 2025
Amount: $750,000 over three years
These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. This award is not intended to be the main source of funding for the applicant’s lab. Applicants must demonstrate multi-year independent funding that sustains the central activities of the lab.
Projects must be centered on evidence-based laboratory, data, and/or medical science.
Eligibility: MD, PhD or equivalent is required.
Must be 3 to 8 years from the start of an independent faculty research appointment as of 12/31/2025 (i.e., the official start date of the appointment must fall within the calendar years 2017-2022).
| | | |
2025 Feldstein Medical Foundation Grant | |
The Feldstein Medical Foundation (FMF) is a private, not-for-profit foundation created to promote and advance medical research, including new or innovative areas of research or smaller, seed-type projects.
They are specifically interested in funding:
-
Promising junior investigators (Assistant Professor level) with a history of some prior funding.
- New or innovative research.
- Research in areas where FMF funding will have the maximum beneficial impact on health or healthcare practice for significant populations.
- Research that may lead to significant advancements in scientific knowledge.
Einstein has been invited to submit TWO candidates: one in the category of Basic Science Research and one in Translational Research/Clinical Research/Medical Education Research. Accepted projects will be funded for a period of up to 1 year, with total costs of up to $80,000 (a maximum of 10% indirect costs may be included in that total).
All applicants must:
- Have a doctoral degree (or equivalent) in a field related to medicine, nursing, public health, health care or biomedical sciences
- Have an Einstein faculty appointment.
-
Demonstrate the research skills, knowledge, and resources to carry out the research successfully. Junior investigators (assistant professor level) with a history of some prior funding are encouraged to apply.
The deadline for submission of preliminary applications to the Office of Grant Support for internal review by Einstein’s Awards Committee is 5 PM, Friday, February 28, 2025.
For the internal review, please send ONE PDF file containing the following as an email attachment to Indranil.basu@einsteinmed.edu -
-
Candidate Profile Form – click here.
- A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than TWO single-spaced pages. This should include the importance of the investigator to the proposed research and the institution’s commitment to that research project.
-
A written proposal that must include the title, background, goals, procedures, and significance of the proposed research project to be carried out during the grant period, limited to no more than three single-spaced pages, plus one additional page (single-spaced) for references with titles included. The font should be 11-point or larger. Figure legends can use smaller fonts. You must indicate in which of the two categories your application fits.
-
A complete curriculum vitae and bibliography. Include invited presentations, not abstracts. Please click here to find the recommended format for curriculum vitae.
- Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award.
For any additional information about FMF and the external application process, or if you have any questions concerning this award or the internal application procedure, please contact Indranil.basu@einsteinmed.edu.
| | | |
2026 PEW SCHOLARS PROGRAM IN BIOMEDICAL SCIENCES | |
The Pew Scholars Program in the Biomedical Sciences provides funding to support assistant professors who, based on their performance during their education and training, demonstrate outstanding promise as contributors in science relevant to the advancement of human health. The funding for clinical trials research is not provided by this program. The inclusion of creative and pioneering approaches to basic, translational, and applied biomedical research in strong proposals is essential. Candidates whose work is based on biomedical principles but brings in concepts and theories from more diverse fields are encouraged to apply. Awards are $75,000 per year for 4 years. Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew Scholars Program. Einstein may nominate ONE candidate for the 2026 Pew Scholars Program.
Eligibility criteria:
- Candidates must have been awarded a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
-
As of Sept. 3, 2025, nominees must be running an independent lab and hold full-time appointments at the rank of assistant professor or equivalent. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are NOT eligible.
-
Candidates must NOT have been appointed as an assistant professor at any institution prior to June 11, 2021, whether or not such appointment was on a tenure track. Time spent on clinical internships, residencies, on work towards board certification, or on parental leave does not count as part of this four-year limit.
The deadline for submission of preliminary applications for internal review by Einstein’s Awards Committee is 5 PM, Friday, April 18th, 2025.
Please send ONE PDF file containing the following as an email attachment to Indranil.basu@einsteinmed.edu:
-
Candidate Profile Form (here).
- A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than TWO single-spaced pages.
- A written proposal containing a title and a description of the proposed research project to be carried out during the grant period, limited to no more than THREE single-spaced pages, plus one additional page (single-spaced) for references with titles included. The font should be 11-point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts.
- A complete curriculum vitae and bibliography. Do NOT submit an NIH biosketch.
- Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award.
Complete guidelines for this program can be found by clicking here.
If you have any questions concerning this award or the application procedure, please contact Indranil.basu@einsteinmed.edu.
| | | |
2026 PEW-STEWART SCHOLARS PROGRAM FOR CANCER RESEARCH | |
The Pew-Stewart Scholars for Cancer Research aids assistant professors with exceptional promise in science that is crucial for the advancement of a cure for cancer. Awards are $75,000 per year for 4 years. Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew-Stewart program. Einstein may nominate ONE candidate for the 2026 Pew-Stewart Scholars Program for Cancer Research. Applications are invited from candidates conducting cancer research.
This program is not the same as the Pew Scholars Program, and it follows a different but parallel set of guidelines and procedures for nominating an applicant whose research is related to cancer. The same applicant cannot apply for both programs at the same time. Please indicate in your application which program you are applying for: Biomedical Sciences (Pew Scholars) or Cancer Research (Pew-Stewart Scholars).
Eligibility criteria:
- Candidates must have been awarded a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
-
As of Aug. 27, 2025, nominees must be running an independent lab and hold full-time appointments at the rank of assistant professor or equivalent. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are NOT eligible.
-
Candidates must NOT have been appointed as an assistant professor at any institution prior to June 11, 2021, whether or not such appointment was on a tenure track. Time spent on clinical internships, residencies, on work towards board certification, or on parental leave does not count as part of this four-year limit.
The deadline for submission of preliminary applications for internal review by Einstein’s Awards Committee is 5 PM, Friday, April 18th, 2025.
Please send ONE PDF file containing the following as an email attachment to Indranil.basu@einsteinmed.edu:
-
Candidate Profile Form (here).
- A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than TWO single-spaced pages.
- A written proposal containing a title and a description of the proposed research project to be carried out during the grant period, limited to no more than THREE single-spaced pages, plus one additional page (single-spaced) for references with titles included. The font should be 11-point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts.
-
A complete curriculum vitae and bibliography. Do NOT submit an NIH biosketch.
- Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award.
Complete guidelines for this program can be found by clicking here.
If you have any questions concerning this award or the application procedure, please contact Indranil.basu@einsteinmed.edu.
| | | | | | |